Characteristics | Univariate analysis OR (95% CI) | p value | Multivariate regression OR (95% CI) | p value |
---|---|---|---|---|
SUVmax of mediastinal lymph node | ||||
< 2.49 | Reference | Reference | ||
≥ 2.49 | 6.947 (3.551–13.591) | < 0.001 | 7.215 (3.326–15.649) | < 0.001 |
Primary-tumor SUVmax | ||||
< 4.11 | Reference | |||
≥ 4.11 | 5.600 (2.272–13.801) | < 0.001 | ||
Primary-tumor SUVpeak | ||||
< 2.92 | Reference | Reference | ||
≥ 2.92 | 6.021 (2.444–14.829) | < 0.001 | 5.717 (2.094–15.605) | 0.001 |
Primary-tumor SUVmean | ||||
< 2.39 | Reference | |||
≥ 2.39 | 5.077 (2.058–12.525) | < 0.001 | ||
Primary-tumor MTV (cm3) | ||||
< 30.88 | Reference | |||
≥ 30.88 | 2.388 (1.244–4.583) | 0.009 b | ||
Primary-tumor TLG | ||||
< 83.53 | Reference | |||
≥ 83.53 | 2.737 (1.460–5.128) | < 0.002 | ||
Degree of primary-tumor solidity | ||||
Partial solid | Reference | |||
solid | 5.429 (2.321–12.697) | < 0.001 | ||
CEA (ng/ml) | ||||
< 3.94 | Reference | Reference | ||
≥ 3.94 | 3.394 (1.800–6.400) | < 0.001 | 2.467 (1.182–5.149) | 0.016 |
CYFRA21-1 (ng/ml) | ||||
< 2.10 | Reference | |||
≥ 2.10 | 2.642 (1.116–6.252) | 0.027 | ||
CA19-9 (U/ml) | ||||
< 16.6 | Reference | |||
≥ 16.6 | 2.234 (1.168–4.273) | 0.015 | ||
SCC (ng/ml) | ||||
< 16.6 | 2.052 (1.023–4.113) | 0.043 | 4.795 (2.019–11.388) | < 0.001 |
≥ 16.6 | Reference | Reference | ||
NSE (ng/ml) | ||||
< 14.66 | Reference | |||
≥ 14.66 | 1.976 (1.051–3.713) | 0.034 |